Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Open-label, Comparative Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia (IDA-04)

Trial Profile

A Randomized, Open-label, Comparative Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia (IDA-04)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 25 Mar 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ferric derisomaltose (Primary) ; Ferric carboxymaltose
  • Indications Iron deficiency anaemia
  • Focus Therapeutic Use
  • Acronyms IDA-04; The PHOSPHARE-IDA04
  • Sponsors Pharmacosmos
  • Most Recent Events

    • 25 Mar 2019 Primary endpoint (Incidence of hypophosphatemia (defined as s-phosphate 2 mg/dL)) has been met, according to the Pharmacosmos media release.
    • 25 Mar 2019 Pooled analysis results from this and other study (700287537) presented in the Pharmacosmos media release.
    • 18 Mar 2019 Results of pooled analyses (PHOSPHARE-IDA04/05 trials) presented at the 101st Annual Meeting of the Endocrine Society
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top